2024
|
P/S
|
Provision of medical research information and scientific
information in the field of oncology. |
|
P/S
|
Provision of medical research information and scientific information in the field of oncology. |
|
P/S
|
Scientific research in the field of prevention and treatment of metabolic disease; providing medi... |
|
P/S
|
Medical and scientific research in the fields of metabolic diseases, providing medical and scient... |
|
P/S
|
Medical and scientific research in the fields of metabolic diseases; providing medical and scient... |
|
P/S
|
Pharmaceutical preparations. |
|
P/S
|
Scientific research in the field of prevention and treatment of metabolic diseases; providing med... |
|
P/S
|
Scientific research in the field of prevention and treatment
of metabolic diseases; providing me... |
|
P/S
|
Medical and scientific research in the fields of metabolic
diseases, providing medical and scien... |
|
P/S
|
Medical and scientific research in the field of mental health; providing medical and scientific r... |
|
P/S
|
Medical and scientific research in the field of mental
health; providing medical and scientific ... |
|
P/S
|
Medical and scientific research in the field of inflammatory diseases; providing medical and scie... |
|
P/S
|
Medical and scientific research in the field of inflammatory
diseases; providing medical and sci... |
|
Invention
|
Anti il-36r antibodies.
The present invention relates to anti-IL-36R binding compounds, in parti... |
|
P/S
|
Scientific research in the field of prevention and treatment of cardiovascular diseases; providin... |
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the ali... |
|
P/S
|
Medical and scientific research in the fields of metabolic
diseases; providing medical and scien... |
|
Invention
|
Novel substituted pyrazine-carboxamide derivatives.
The present invention relates to compounds o... |
|
Invention
|
Cardiosafe antidiabetic therapy.
The present invention relates to cardio-safe antidiabetic therapy |
|
Invention
|
Cardio- and renosafe antidiabetic therapy.
The present invention relates to cardio- and renosafe... |
|
Invention
|
Anti-il-36r antibodies for the treatment of neutrophilic dermatoses.
The present invention provi... |
|
Invention
|
Substituted 1h-pyrazolo[4,3-c]pyridines and derivatives as egfr inhibitors.
The present inventio... |
|
Invention
|
Methods for the treatment of gpp.
The present invention relates to the treatment of or alleviati... |
|
Invention
|
Treatment of cognitive impairment associated with schizophrenia.
The invention relates to the tr... |
|
Invention
|
Pharmaceutical composition, methods for treating and uses thereof.
The invention relates to a ph... |
|
Invention
|
Holding device for dispensing devices for substance dispensing of at least one therapeutically an... |
|
Invention
|
Methods for the treatment and prevention of gpp.
The present invention relates to the treatment ... |
|
Invention
|
Methods for the treatment and prevention of gpp. The present invention relates to the treatment o... |
|
Invention
|
Pyridine derivatives with n-linked cyclic substituents as cgas inhibitors.
The invention relates... |
|
Invention
|
Spirocyclic annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer.
Th... |
|
Invention
|
Survivin as a biomarker for predicting the responsiveness of cancer treatment. The present invent... |
|
Invention
|
Spirocyclic annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer. The... |
|
Invention
|
Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome.
The present i... |
|
Invention
|
Uses of t cell engaging proteins in the treatment of cancer. The invention generally relates to t... |
|
Invention
|
Uses of t cell engaging proteins in the treatment of cancer.
The invention generally relates to ... |
|
Invention
|
Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations... |
|
Invention
|
Formulations to stabilize virus-based therapeutics.
The present invention relates to viral formu... |
|
Invention
|
Formulations to stabilize virus-based therapeutics. The present invention relates to viral formul... |
|
Invention
|
7-(4-chlorobenzyl)-1-(3-hydroxypropyl)-3-methyl-8-(3-(trifluoromethoxy)-phenoxy)-3,7-dihydro-1h-p... |
|
Invention
|
Methods for continuously inactivating a virus during manufacture of a protein.
Methods for conti... |
|
Invention
|
Heterobicyclic amides as inhibitors of cd38.
The present invention relates to heterobicyclic ami... |
|
Invention
|
Dosing schedule of a her2 inhibitor. The present invention relates to a dosing schedule of a HER2... |
|
Invention
|
Formulations comprising polysorbate. Formulations comprising polysorbate and citrate are disclose... |
|
Invention
|
New polymorphs for a piperidino-dihydrothienopyrimidine sulfoxide. The invention concerns new cry... |
|
Invention
|
Phenylpiperidine derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-... |
|
Invention
|
Use of anti-il-36r antibodies for the treatment of hidradentitis suppurativa (hs).
The invention... |
|
Invention
|
Use of anti-il-36r antibodies for the treatment of hidradentitis suppurativa (hs). The invention ... |
|
Invention
|
Method for testing the integrity of virus filtration modules and a filtration apparatus for carry... |
|
Invention
|
New therapeutic combinations for the treatment of progressive fibrosing interstitial lung disease... |
|
Invention
|
[1,3]thiazolo[4,5-d]-pyrimidon-7-ones as inhibitors of nox4.
The present disclosure provides [1,... |
|
Invention
|
Use of anti-cd40 antibodies for treatment of inflammatory conditions.
The present invention rela... |
|
Invention
|
[1,3]thiazolo[4,5-d]-pyrimidin-7-ones as inhibitors of nox4. The present disclosure provides [1,3... |
|
Invention
|
Anti-sema3a antibodies and their uses for treating eye or ocular diseases.
The present invention... |
2023
|
Invention
|
Anti-cd40 antibodies for use in treating autoimmune disease.
The present invention relates to ne... |
|
Invention
|
Tetrazole derivatives as trpa1 inhibitors.
The present disclosure provides certain tetrazole der... |
2022
|
Invention
|
Trpc6 inhibitory compounds for treating sepsis.
The present invention relates to compounds of fo... |
|
Invention
|
Adamts14 inhibition.
Methods of treating and preventing fibrosis, and diseases/disorders charact... |
|
Invention
|
Quantification method of polysorbate in aqueous formulations.
The present disclosure is directed... |
|
Invention
|
Medicament for preventing and/or treating dry eye.
A compound useful for preventing or treating ... |
|
Invention
|
Method of determining a future color value or corresponding property and arrangement therefor.
T... |
|
Invention
|
Anti-il1rap antibodies.
The present invention relates to anti-IL1RAP binding compounds, in parti... |
2021
|
Invention
|
Formulation for multi-purpose application.
The present invention relates in general to the formu... |